• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎患者的 TNF-α 信使核糖核酸(mRNA)。

TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis.

机构信息

Faculty of Medicine, St. Joseph University, Beirut, Lebanon.

出版信息

Eur Cytokine Netw. 2012 Jul-Sep;23(3):107-11. doi: 10.1684/ecn.2012.0313.

DOI:10.1684/ecn.2012.0313
PMID:23009757
Abstract

BACKGROUND AND AIM

tumor necrosis factor (TNF)-α plays a significant role in the pathogenesis of nonalcoholic steatohepatitis (NASH). A few studies have confirmed high TNF-α plasma protein levels in patients with NASH compared to healthy volunteers. We herein aimed to revisit these findings using other molecular techniques.

METHODS

a cross-sectional evaluation of patients newly diagnosed with NASH. A quantitative assay for the measurement of TNF-α messenger ribonucleic acid (mRNA) was performed for NASH patients and controls using real-time reverse transcription polymerase chain reaction (RT-PCR).

RESULTS

in 39 patients with NASH (mean age 38.6 ± 9.4 years, range 28-60 years; 79% males), the mean TNF-α mRNA level was significantly higher than that found for controls (137.6 ± 102.3 ng/mL versus 83.5 ± 43.8 ng/mL, respectively; P = 0.012). A TNF-α mRNA cut-off of 100 ng/mL predicted NASH most optimally (AUC 0.685 ± 0.066, P = 0.01; with 66.7% sensitivity and 74.1% specificity). Serum TNF-α and soluble TNF-α receptor II (sTNFRII) levels were significantly higher in patients compared to controls using ELISA.

CONCLUSION

high TNF-α mRNA levels, determined by RT-PCR, characterize patients with NASH.

摘要

背景与目的

肿瘤坏死因子(TNF)-α在非酒精性脂肪性肝炎(NASH)的发病机制中起重要作用。一些研究证实,与健康志愿者相比,NASH 患者的 TNF-α 血浆蛋白水平较高。我们旨在使用其他分子技术重新验证这些发现。

方法

对新诊断为 NASH 的患者进行横断面评估。使用实时逆转录聚合酶链反应(RT-PCR)对 NASH 患者和对照组进行 TNF-α 信使核糖核酸(mRNA)的定量测定。

结果

在 39 例 NASH 患者(平均年龄 38.6 ± 9.4 岁,范围 28-60 岁;79%为男性)中,TNF-α mRNA 水平明显高于对照组(分别为 137.6 ± 102.3 ng/mL 和 83.5 ± 43.8 ng/mL;P = 0.012)。TNF-α mRNA 截断值为 100 ng/mL 可最佳预测 NASH(AUC 0.685 ± 0.066,P = 0.01;敏感性为 66.7%,特异性为 74.1%)。ELISA 显示,与对照组相比,患者的血清 TNF-α 和可溶性 TNF-α 受体 II(sTNFRII)水平明显更高。

结论

通过 RT-PCR 确定的高 TNF-α mRNA 水平可用于表征 NASH 患者。

相似文献

1
TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的 TNF-α 信使核糖核酸(mRNA)。
Eur Cytokine Netw. 2012 Jul-Sep;23(3):107-11. doi: 10.1684/ecn.2012.0313.
2
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.非酒精性脂肪性肝炎患者中肿瘤坏死因子α及肿瘤坏死因子受体p55和p75的基因表达
Hepatology. 2001 Dec;34(6):1158-63. doi: 10.1053/jhep.2001.29628.
3
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?非酒精性脂肪性肝炎中的胰岛素抵抗之外:肿瘤坏死因子-α还是脂联素?
Hepatology. 2004 Jul;40(1):46-54. doi: 10.1002/hep.20280.
4
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者血清透明质酸、肿瘤坏死因子-α和白细胞介素-8水平
Hepatogastroenterology. 2005 Sep-Oct;52(65):1549-53.
5
Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).脂肪激素作为非酒精性脂肪性肝炎(NASH)患者的预后标志物。
J Physiol Pharmacol. 2009 Oct;60 Suppl 3:71-5.
6
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎患者的血清细胞因子及可溶性细胞因子受体水平
Liver Int. 2006 Feb;26(1):39-45. doi: 10.1111/j.1478-3231.2005.01191.x.
7
Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.血浆五聚素3可区分非酒精性脂肪性肝炎(NASH)与非NASH。
Metab Syndr Relat Disord. 2015 Nov;13(9):393-9. doi: 10.1089/met.2015.0046. Epub 2015 Sep 14.
8
Real-time reverse transcription-polymerase chain reaction quantification of tumor necrosis factor alpha messenger in human leukocytes.人白细胞中肿瘤坏死因子α信使核糖核酸的实时逆转录-聚合酶链反应定量分析
Clin Lab. 2011;57(9-10):799-802.
9
Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.非酒精性脂肪性肝炎患者血清细胞间黏附分子-1:与酒精性肝炎的比较
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7. doi: 10.1111/j.1530-0277.2006.00292.x.
10
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.评价非酒精性脂肪性肝病患者的炎症和血管生成因子。
Cytokine. 2012 Aug;59(2):442-9. doi: 10.1016/j.cyto.2012.05.001. Epub 2012 May 31.

引用本文的文献

1
The Role of CD4T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.CD4T 细胞在非酒精性脂肪性肝炎和肝细胞癌中的作用。
Int J Mol Sci. 2024 Jun 23;25(13):6895. doi: 10.3390/ijms25136895.
2
A potential link between plasma short-chain fatty acids, TNF-α level and disease progression in non-alcoholic fatty liver disease: A retrospective study.血浆短链脂肪酸、TNF-α水平与非酒精性脂肪性肝病疾病进展之间的潜在联系:一项回顾性研究
Exp Ther Med. 2022 Jul 28;24(3):598. doi: 10.3892/etm.2022.11536. eCollection 2022 Sep.
3
Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.
肝脏硬度测量可在无明显心脏疾病的非进展期非酒精性脂肪性肝病患者中识别亚临床心肌功能障碍。
Intern Emerg Med. 2022 Aug;17(5):1425-1438. doi: 10.1007/s11739-022-02966-2. Epub 2022 Mar 17.
4
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.炎症标志物在脂肪性肝病诊断或风险预测中的应用:争议与机遇
Front Immunol. 2021 Feb 9;11:634409. doi: 10.3389/fimmu.2020.634409. eCollection 2020.
5
Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer.血清生物标志物将小鼠脂肪性肝炎的超声特征与肝癌联系起来。
Nutr Metab (Lond). 2018 Oct 5;15:71. doi: 10.1186/s12986-018-0304-9. eCollection 2018.
6
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.脂肪组织功能障碍、维生素 D 缺乏与非酒精性脂肪性肝病发病机制的关系。
World J Gastroenterol. 2017 May 21;23(19):3407-3417. doi: 10.3748/wjg.v23.i19.3407.
7
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.非酒精性脂肪性肝病:诊断与治疗挑战的最新进展
Clin Mol Hepatol. 2016 Sep;22(3):327-335. doi: 10.3350/cmh.2016.0049. Epub 2016 Sep 25.
8
Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.非酒精性脂肪性肝炎对阿德福韦肾滤过及分泌的影响。
Biochem Pharmacol. 2016 Sep 1;115:144-51. doi: 10.1016/j.bcp.2016.07.001. Epub 2016 Jul 2.
9
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.非酒精性脂肪性肝炎中的肝损伤导致肠道通透性改变。
Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. doi: 10.1016/j.jcmgh.2015.01.001.
10
Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway.非酒精性脂肪性肝炎:可用治疗选择有限,但有前景的药物正在研发中,且在监管审批途径方面取得了近期进展。
Drugs. 2015 Aug;75(12):1373-92. doi: 10.1007/s40265-015-0437-3.